RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/28426646/ below:

Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017

Practice Guideline

. 2017 Apr 21;66(1):1-34. doi: 10.15585/mmwr.rr6601a1. Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017

Collaborators, Affiliations

Collaborators

CDC Community Mitigation Guidelines Work Group: Alexandra Levitt⁷, Stephanie Dopson⁸, Mark Frank⁸, Rachel Holloway⁸, Lisa Koonin⁸, Sonja Rasmussen⁸, Stephen Redd⁸, Christopher de la Motte Hurst⁹, Neha Kanade⁹, Noreen Qualls⁹, Jeanette Rainey⁹, Amra Uzicanin⁹, Matthew Biggerstaff¹⁰, Daniel Jernigan¹⁰, Carrie Reed¹⁰

Affiliations

¹ Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
² Office of Infectious Diseases, CDC, Atlanta, Georgia.
³ Eagle Medical Services, San Antonio, Texas.
⁴ Karna, Atlanta, Georgia.
⁵ Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta, Georgia.
⁶ Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.
⁷ Office of Infectious Diseases, CDC.
⁸ Influenza Coordination Unit, Office of Infectious Diseases, CDC.
⁹ Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
¹⁰ Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.

PMID: 28426646
PMCID: PMC5837128
DOI: 10.15585/mmwr.rr6601a1

Item in Clipboard

Practice Guideline

Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017

Noreen Qualls et al. MMWR Recomm Rep. 2017.

. 2017 Apr 21;66(1):1-34. doi: 10.15585/mmwr.rr6601a1. Collaborators

CDC Community Mitigation Guidelines Work Group: Alexandra Levitt⁷, Stephanie Dopson⁸, Mark Frank⁸, Rachel Holloway⁸, Lisa Koonin⁸, Sonja Rasmussen⁸, Stephen Redd⁸, Christopher de la Motte Hurst⁹, Neha Kanade⁹, Noreen Qualls⁹, Jeanette Rainey⁹, Amra Uzicanin⁹, Matthew Biggerstaff¹⁰, Daniel Jernigan¹⁰, Carrie Reed¹⁰

Affiliations

¹ Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia.
² Office of Infectious Diseases, CDC, Atlanta, Georgia.
³ Eagle Medical Services, San Antonio, Texas.
⁴ Karna, Atlanta, Georgia.
⁵ Division of State and Local Readiness, Office of Public Health Preparedness and Response, CDC, Atlanta, Georgia.
⁶ Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.
⁷ Office of Infectious Diseases, CDC.
⁸ Influenza Coordination Unit, Office of Infectious Diseases, CDC.
⁹ Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
¹⁰ Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.

PMID: 28426646
PMCID: PMC5837128
DOI: 10.15585/mmwr.rr6601a1

Item in Clipboard

Abstract

When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available. NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, including seasonal and pandemic influenza viruses.These guidelines replace the 2007 Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions (https://stacks.cdc.gov/view/cdc/11425). Several elements remain unchanged from the 2007 guidance, which described recommended NPIs and the supporting rationale and key concepts for the use of these interventions during influenza pandemics. NPIs can be phased in, or layered, on the basis of pandemic severity and local transmission patterns over time. Categories of NPIs include personal protective measures for everyday use (e.g., voluntary home isolation of ill persons, respiratory etiquette, and hand hygiene); personal protective measures reserved for influenza pandemics (e.g., voluntary home quarantine of exposed household members and use of face masks in community settings when ill); community measures aimed at increasing social distancing (e.g., school closures and dismissals, social distancing in workplaces, and postponing or cancelling mass gatherings); and environmental measures (e.g., routine cleaning of frequently touched surfaces).Several new elements have been incorporated into the 2017 guidelines. First, to support updated recommendations on the use of NPIs, the latest scientific evidence available since the influenza A (H1N1)pdm09 pandemic has been added. Second, a summary of lessons learned from the 2009 H1N1 pandemic response is presented to underscore the importance of broad and flexible prepandemic planning. Third, a new section on community engagement has been included to highlight that the timely and effective use of NPIs depends on community acceptance and active participation. Fourth, to provide new or updated pandemic assessment and planning tools, the novel influenza virus pandemic intervals tool, the Influenza Risk Assessment Tool, the Pandemic Severity Assessment Framework, and a set of prepandemic planning scenarios are described. Finally, to facilitate implementation of the updated guidelines and to assist states and localities with prepandemic planning and decision-making, this report links to six supplemental prepandemic NPI planning guides for different community settings that are available online (https://www.cdc.gov/nonpharmaceutical-interventions).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The CDC contributors wish to disclose that they have no financial or competing interests or other relationships that would unfairly influence these CDC guidelines and recommendations.

Figures
FIGURE 1

Goals of community mitigation for…

FIGURE 1

Goals of community mitigation for pandemic influenza Source: Adapted from: CDC. Interim pre-pandemic…

FIGURE 1

Goals of community mitigation for pandemic influenza Source: Adapted from: CDC. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States—early, targeted, layered use of nonpharmaceutical interventions. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. https://stacks.cdc.gov/view/cdc/11425 .

FIGURE 2

Preparedness and response framework for…

FIGURE 2

Preparedness and response framework for novel influenza A virus pandemics, with CDC intervals…

FIGURE 2

Preparedness and response framework for novel influenza A virus pandemics, with CDC intervals and World Health Organization phases Source: Adapted from: Holloway R, Rasmussen SA, Zaza S, Cox NJ, Jernigan DB; Influenza Pandemic Framework Workgroup. Updated preparedness and response framework for influenza pandemics. MMWR Recomm Rep 2014;63(No. RR-6).

FIGURE 3

Pandemic Severity Assessment Framework for…

FIGURE 3

Pandemic Severity Assessment Framework for the initial assessment of the potential impact of…

FIGURE 3

Pandemic Severity Assessment Framework for the initial assessment of the potential impact of an influenza pandemic Source: Reed C, Biggerstaff M, Finelli L, et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg Infect Dis 2013;19:85–91.

FIGURE 4

Pandemic Severity Assessment Framework using…

FIGURE 4

Pandemic Severity Assessment Framework using surveillance indicators for the refined assessment of an…

FIGURE 4

Pandemic Severity Assessment Framework using surveillance indicators for the refined assessment of an influenza pandemic on the basis of past pandemics and influenza seasons Source: Adapted from: Reed C, Biggerstaff M, Finelli L, et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg Infect Dis 2013;19:85–91. * Colors transition from light to dark as the estimated number of deaths increases. Transmissibility: measured on a scale of 1–5 and includes school, workplace, and community attack rates, secondary household attack rates, school and/or workplace absenteeism rates, and rates of emergency department and outpatient visits for influenza-like illness. Clinical severity: measured on a scale of 1–7 and includes case-fatality ratios, case-hospitalization ratios, and deaths-hospitalizations ratios.

FIGURE 5

Phased addition of nonpharmaceutical interventions…

FIGURE 5

Phased addition of nonpharmaceutical interventions to prevent the spread of pandemic influenza in…

FIGURE 5

Phased addition of nonpharmaceutical interventions to prevent the spread of pandemic influenza in communities Abbreviation: NPI = nonpharmaceutical intervention.

FIGURE 6

U.S. Department of Health and…

FIGURE 6

U.S. Department of Health and Human Services pandemic planning scenarios based on the…

FIGURE 6

U.S. Department of Health and Human Services pandemic planning scenarios based on the Pandemic Severity Assessment Framework Source: Adapted from: Reed C, Biggerstaff M, Finelli L, et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg Infect Dis 2013;19:85–91.